Edelstein Paul H, Hu Baofeng, Edelstein Martha A C
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine and Clinical Microbiology Laboratory, Hospital of the University of Pennsylvania, Philadelphia, PA 19104-4283, USA.
Antimicrob Agents Chemother. 2005 Jun;49(6):2533-5. doi: 10.1128/AAC.49.6.2533-2535.2005.
LBM415 activity against extracellular and intracellular Legionella pneumophila was studied. The LBM415 MIC50 for 20 Legionella sp. strains was 4 microg/ml, versus 0.06, 0.25, and <or=0.03 microg/ml for azithromycin, erythromycin, and levofloxacin, respectively. LBM415 (0.5 and 16 microg/ml) reversibly prevented intracellular growth of two L. pneumophila strains and was less active than erythromycin.
研究了LBM415对细胞外和细胞内嗜肺军团菌的活性。LBM415对20株军团菌属菌株的MIC50为4微克/毫升,而阿奇霉素、红霉素和左氧氟沙星的MIC50分别为0.06、0.25和≤0.03微克/毫升。LBM415(0.5和16微克/毫升)可可逆地阻止两株嗜肺军团菌的细胞内生长,且活性低于红霉素。